Entomopoxvirus-vertebrate gene delivery vector and method
US6106825A · kind A · utility
Assignee
Inventors
Key dates
| Filing date | May 7, 1997 |
| Grant date | Aug 22, 2000 |
| Priority date | — |
| Expiry date | May 7, 2017 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2710/24043
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention provides recombinant entomopoxvirus as a novel vector and method of using such vector for delivery and expression of genes of biological significance to vertebrate cells, including human cells. This invention includes the use of an early entomopoxvirus or like gene promoter to drive the expression of an heterologous gene product in a vertebrate cell infected with the recombinant entomopoxvirus vector. We have discovered that, while the entomopoxvirus vector of this invention does not replicate in the vertebrate cell, it enters vertebrate cell cytoplasm and achieves expression of an heterologous gene inserted into the rEPV without causing cytopathic or cytotoxic effects. We further provide a method for expression of the heterologous gene under control of late, strong entomopoxvirus gene promoters, vertebrate gene or viral promoters, and for stable integration of the heterologous gene delivered by the rEPV into the vertebrate cell.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.